Biogen Pharmachem Industries Ltd — Important, 18-05-2026: Company Update

Biogen Pharmachem Industries' Board allotted 15.04 Cr bonus equity shares to eligible shareholders. This increases the company's paid-up and issued capital from Rs. 90.26 Cr to Rs. 105.30 Cr. This move expands the equity base and provides existing shareholders with additional shares, reflecting a capitalization of reserves and a potential boost to liquidity without a cash outflow for the company. The shares have been credited to shareholder accounts.